Skip to main content

Advertisement

Table 4 Differences between groups regarding primary and secondary outcome measures

From: The effectiveness of the Austrian disease management programme for type 2 diabetes: a cluster-randomised controlled trial

  mean difference1 95%-CI p-value2
Primary outcome measure
HbA1c (%) -0.13 [-0.24; -0.02] 0.026
Secondary outcome measures
Creatinine (μmol/l) 1.77 [-0.88; 4.42] 0.157
Triglycerides (mmol/l) -0.06 [-0.21; 0.09] 0.417
Cholesterol (mmol/l) -0.05 [-0.16; 0.05] 0.291
HDL (mmol/l) 0.01 [-0.01; 0.04] 0.295
LDL (mmol/l) 0.05 [-0.04; 0.14] 0.314
RR systolic (mmHg) -1.80 [-3.65; 0.05] 0.057
RR diastolic (mmHg) -0.55 [-1.62; 0.51] 0.307
BMI -0.27 [-0.45; -0.08] 0.004
  1. 1 Mean difference is calculated as control group value - intervention group value.
  2. 2 independent T-Test, unadjusted